Literature DB >> 21960170

Olfactory function in dialysis patients: a potential key to understanding the uremic state.

Andrew S Bomback, Amanda C Raff.   

Abstract

Impaired olfactory function is a marker of neurologic dysfunction in the uremic state. Retained uremic toxins not adequately cleared with dialysis may undermine the integrity of the olfactory epithelium and olfactory bulb and malign central olfactory processing. The evidence suggests that only renal transplantation, with its concomitant thorough reversal of uremia, truly restores olfactory function to normal in end-stage renal disease. Testing of olfactory function may emerge as an important marker for the extent and resolution of uremia.

Entities:  

Mesh:

Year:  2011        PMID: 21960170     DOI: 10.1038/ki.2011.219

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Characterization and Correction of Olfactory Deficits in Kidney Disease.

Authors:  Sagar U Nigwekar; Jeremy M Weiser; Sahir Kalim; Dihua Xu; Joshua L Wibecan; Sarah M Dougherty; Laurence Mercier-Lafond; Kristin M Corapi; Nwamaka D Eneanya; Eric H Holbrook; Dennis Brown; Ravi I Thadhani; Teodor G Păunescu
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Uremia presented as acute cranial neuropathy.

Authors:  Wook Hur; Ji Yeon Chung; Pahn Kyu Choi; Hyun Goo Kang
Journal:  Neurol Sci       Date:  2019-02-01       Impact factor: 3.307

3.  Human-Like Sensing and Reflexes of Graphene-Based Films.

Authors:  Qin Zhang; Lifang Tan; Yunxu Chen; Tao Zhang; Wenjie Wang; Zhongfan Liu; Lei Fu
Journal:  Adv Sci (Weinh)       Date:  2016-06-13       Impact factor: 16.806

4.  Olfaction and kidney function in community-dwelling older adults.

Authors:  Keran Wang; Zhehui Luo; Chenxi Li; Jayant M Pinto; Eric J Shiroma; Eleanor M Simonsick; Honglei Chen
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

5.  Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Authors:  Miklós Palkovits; Katarína Šebeková; Kristina Simon Klenovics; Anton Kebis; Gholamreza Fazeli; Udo Bahner; August Heidland
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

6.  Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study.

Authors:  Valentina Iacono; Gianmarco Lombardi; Giancarlo Ottaviano; Giovanni Gambaro; Gianluigi Zaza
Journal:  J Nephrol       Date:  2021-02-24       Impact factor: 3.902

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.